Eugene

[email protected]

LATEST

AstraZeneca, Ionis in Pact for Antisense Drug for Kidney Disease
By

By
AstraZeneca and Ionis Pharmaceuticals, a Carlsbad, California-based pharmaceutical company, have formed an agreement in which AstraZeneca will license Ionis’ IONIS-AZ5-2.5Rx, an antisense drug. IONIS-AZ5-2.5Rx was discovered by Ionis, and it…

Takeda, Wave Life Sciences in Oligonucleotide Drug Pact
By

By
Takeda Pharmaceutical Company has formed a pact and multi-program option agreement with Wave Life Sciences, a Cambridge, Massachusetts-headquartered biopharmaceutical company, to develop antisense oligonucleotides for genetically defined neurological diseases. The…

Hikma Pharmaceuticals Appoints Former Teva Executive as CEO
By

By
Hikma Pharmaceuticals, an Amman, Jordan-based pharmaceutical company, has appointed Sigurdur Olafsson, a former executive at Teva Pharmaceutical Industries, as chief executive officer (CEO). Olafsson will also join Hikma’s Board of…

Mylan Leads Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Mylan. Editor’s Note: This article was updated on a continuous basis for news…

AbbVie Forms Neurodegenerative Disease Pact Worth up to $1.1 Billion
By

By
AbbVie and Voyager Therapeutics, a Cambridge, Massachusetts-headquartered clinical-stage gene-therapy company, have partnered to develop and commercialize vectorized antibodies directed against tau, a protein in the brain that promotes cellular stability,…

Avid Bioservices and Oncologie in Pact for Avid’s mAb
By

By
Oncologie, a Boston, Massachusetts-headquartered biopharmaceutical company developing therapeutics in oncology, has formed an asset assignment and purchase agreement for Avid Bioservices’ phosphatidylserine (PS)-targeting program, including bavituximab. Avid Bioservices is a…

Charles River Labs To Transfer Biologics Testing Operations to New Facility
By

By
Charles River Laboratories, a Wilmington, Massachusetts-headquartered contract research organization (CRO), has acquired a new facility in Wayne, Pennsylvania to use as laboratory space for biologics testing. Along with testing laboratories,…

Colorcon Launches New Tablet-Coating System
By

By
Colorcon, an excipient manufacturer, has launched a new film-coating system called Opadry EZ, Easy Swallow Film Coating System, to address difficulties swallowing oral solid-dosage forms. Source: Colorcon

Astellas Acquires Stem-Cell Technology Company
By

By
Astellas has agreed to acquire Universal Cells, a Seattle, Washington-based biopharmaceutical company. Astellas will gain Universal Cells’ proprietary Universal Donor Cell technology to create cell-therapy products that do not require…

Novartis Partners with Gates Foundation for Parasitic Disease
By

By
Novartis and the Bill & Melinda Gates Foundation have partnered to advance development of Novartis’ drug candidate, KDU731, for treating cryptosporidiosis, a parasitic disease. KDU731 is a cryptosporidium lipid kinase…